Back Matter (PDF) - Clinical Chemistry

More documents

Recommendations

Info

GC-NPD and GC-MS anal, of comm. available Toxi-Disc drugs (A), 1184 identn, of some typical -bhockers (bisoprohol, betaxolol) and prapafenone in bioL specimens: applicn. to doping anal. (A), 1183 improved GCIMS drug detection with chem. ionization mass spectrometry and ion trap detection (A), 1180 isotope diln, GC-MS of metals at trace levels in biol. samples (A), 1113 quant anal. for org. acids in biol, samples: batch isolation followed by gas chromatog.-mass spectrom. anal., 587 simultaneous qusntn. of morphine, codeine, and 06-monoacetyl morphine by gas chromatog. mass spectrom. (A), 1355 urinary org. acid excretion by premature babies, versatile, 1460 efficient system for extracting drugs from urine for gas chromatog./mass spectrom. anal. (SN), 2100 Gastrltls high prevalence of atrophic gastritis in the elderly: implications for health-associated ref. limits for cobalamin in serum (L), 1557 Gastroduodenal ulcers pepsin and pepsinogen group I levels in human gastroduodenal biopsies (A), 1126 Gaucher’. disease immunoassay of band 5 (“tartrate-resistant”) acid phosphatase involving use of antiporcine uteroferrin antibodies, 86 GELLAB See Ehectrophoresis, twa-dimensional Gene probes DNA fingerprinting with nonradioactive gene probes (TB), 2147 Gene synthesis genetically engineered antibodies (5), 1849 Genetic engineering genetically engineered antibodies (S), 1849 Genetics See also Heritable disorders carrier detection and characterization of gene deletions in Duchenne and Becker muscular dystrophy utilizing dystrophin cDNA probes (A), 1075 cm. signif. of genetic rearrangements in neuroblastomas (5), B38 construction of a linkage map of the human gename, and its apphn. to mapping genetic diseases (5), 833 cystic fibrosis: diagnostic testing and the search for the gene (5), B17 DNA flngerprintmg (5), 1832 erythrocyte ferritin assay to find patients with homozygous hemochromatosis (A), 1083 fundamental mechanisms of tumorigenesis in the nervous system: isoln, and charactern, of genes assocd, with hered. forms of cancer (S), 825 genes encoding neuronal nicotinic acetylchohine receptors (S), 731 genetic heterogeneity at the cystic fibrosis locus (A), 1077 genetics of bipolar affective disorder: chin. implications (5), B28 lipoprotain(a): genetic marker for atherosclerosis (A), 1234 loss of heterozygosity in stages of malignancy (S). B48 Lp(a) phenotype frequency in a normal North Am: population (A), 1070 mapping the locus of autosomal dominant polycystic kidney disease: diagnostic eppln. mole, genetics of Duchenne and Becker muscular dystrophy emphasis on improved diagnosis (S), B21 molecular genetics of leukemia and lymphoma (S),B43 moL genetics and the transformation of cm. chem, (S), 2165 oxidation phenotype, comparison between debrisoquine and dextromethorphan tests (A), 1184 recombinant DNA technoL in diagnosis of genetic disorders(S), 84 strong assocn, of a single nucheotide substitution in the 3’-untranslated region of the apohipoprotein.CIII gene with common hypertrighyceridemia in Arabs, 256 use of DNA probes and complement phenotyping for diagnosis and carrier detection in families with steroid 21- hydroxylase deficiency (A), 1075 Gentamicin fluorescence poharn. immunoassay of gentamicin or netilmicin in blood spotted on filter paper (SN), 867 latex agglutination inhibition immunoassay for gentamicin on the IL Monarch’ chem. system (A), 1172 quality assurance study of gentamicin usage and monitoring ins children’s hospital (A), 1167 TDM assays by fluorescence polarization on Cobas Fare 1P5 analyzer; detn. of serum amikacin, gentamicin, and tobramycin (A), 1178 Technicon tobramycin and gentamicin: secondgeneration, improved methods on the RA- 1000 system (A), 1172 Geriatric chemistry bioL variability of 26 din. chem. analytes in the elderly, 783 chin. chem. ref,-intervals for healthy elderly (A), 1061 erythrocyte sedimentation rate and C-reactive protein compared in the elderly (SN), 466 geriatric ther, drug monitoring: special considerations(S), 1337 Gigantism somatotropin as mess. by a two-site timeresolved immunofluorometric assay, 913 Globulins factitiously high Na activities in the Ektachem 400 owing to interferences by high gamma-globulin concns, Glomerular filtration rate (CR), 333 renal function assessed by serum creatinine and creatinine clearance: glomerular filtration rate estd. by four procedures (SN), 2326 Glucitol simple enzymatic method for detg. 1,5- anhydro-D-ghucitol in plasma for diagnosis of diabetes, 2039 Glucocerebrosldsse evaln. of biotinylated (Blugene’) vs 32p labeled cDNA probes of - glucocerebrosidase: rel. sensitivities in genomic and other systems (SN), 1512 Glucosaminidase bioL variation of urinary N.acetyh--Dglucosaminidase: practical and din. implications, 560 intra-individual biol. variation in the N-acetyl- $-glucosaminidsse/creatininium ratio for first morning urine (TB), 1256 Glucose accuracy, precision, and chin, reliability of three capillary blood glucose monitors (A), 1135 aqueous-based glucose control solos. for use with glucose reagent-strips and meters (L), 2017 deth, of glucose using glucose oxidase fixed-time reaction (A), 1105 in a effectiveness of NsF as a preservative of blood glucose (SN), 315 effects of glucose on spectraphotometric detn, of blood D-xylose (A), 1156 enzyme electrode for glucose measurement whole blood with a critical care profiling in instrument (A), 1098 evaln. of APEC glucose analyzer method (A), 1112 evaln, of Beckman Interhink’s custom formatting for reporting glucose tolerance test results (A), 1088 evaln. of Litescan “One Touch” glucometer far a hoep. bedside glucose monitoring program (A), 1107 evaln. of Nova 12: whale-blood and serum electrolyte, glucose, and BUN analyzer (A), 1128 individual home glucose meters evalusted by routine chin. lab, methods (A), 1142 influence of blood 02 tension on dipstick glucose detns. (L), 1268 qua!. control of glucose monitors outside the chin, lab.: use of commercial nonhuman erythrocyte prepns. supplemented with glucose (L), 509 quality-control program for evaluating and monitoring multiple-site reflectance glucose analyses (A), 1160 reagenthess detn, of glucose and other constituents in blood by ATR-FT-IRspectroscapy (5), 1854 relationship between plasma and whole-blood glucose during the glucose tolerance test (A), 1127 reliable bedside glucose tasting ins hospital (A), 1237 simultansous detn, of urea, glucose, Na, K, Cl, and total CO2 in undiluted human serum using an electrode-based automated analyzer (A), 1091 technique-induced errors in two popular blood glucose reagent strips (A), 1156 underestn. of urinary glucose by an automated dipstick analyzer based on glucose oxidase with has indicator chromogen (L), 1804 Glucose-6-phosphate dehydrogensse assay of glucose-S-phosphate dehydrngenase acty. in blood on the Hitachi 737, with simultaneous detn. of Hb (A), 1119 Glucose tolerance test oral glucose tolerance test does not provide a uniform stimulus to pancreatic islets in pregnancy, 1482 relationship between plasma and whole-blood glucose during the glucose tolerance test (A), 1127 Glutsmyhtransfersse high-M, (“biliary”) isoenzyme of alk, phosphataae and the diagnosis of liver dysfunction in cystic fibrosis, 1888 Ghutathioue peroxidsse automated methods for chin, assay of superoxide dismutase and ghutethione peroxidase in human plasma and erythrocytes using a Cobas Bia centrifugal analyser (A), 1126 Glutathione synthetase deficiency pyroghutamic acidemia in an adult (CR), 684 Glutathione S-transferase mess, of glutathione S-transferase B1 in plasma after birth asphyxia: early indication of hepatocellular damage, 995 plasma glutathione S-transferaae and F protein are more sensitive than alanine aminotransferase as markers of acetaminophen-induced liver damage, 2186 Glycated albumin correhn. of HbAic, glycated serum proteins and albumin, and fructosamine with 24-h glucose profile of insulin-dependent pregnant diabetics, 922 Ghycated hemoglobin enzyme immunoassay of Hb Air: anal. characteristics and chin, performance in diabetes mellitus, with and without uremia, 93 fructosamine assay modified for estn. of glycated Rb (TB), 497 glycated Hb and fructosamine measurements in assesaing glycemic control (A), 1236 glycated Rb in fractionated erythrocytes, 958 HPLC detn. of hemoglobin A1,,in the presence of the fast hemoglobin I-Philadelphia (TB), 494 liq.-chromatog. detn. of acetylated Rb, 33 precision of mess. of glycated Rb by affinity chromatog. on regenerated columns (L), 191 quantn. of glycated Hb by alkaline gel ehectrophoresis: the Paragon system (A), 1162 ref. range of glycated Hb in nondiabetic persons possessing Rb S by affmity chromatog. (A), 1162 simplified anal, for glycated Hb by ionexchange chromatog. (L), 2253 Glycated lipoprotein effect of ghycation of law-density lipoprotein on immunolog. detn. of apohipoprotein B (SN), 2219 serum glycated $-lipoprotein detd. by agarose gel ehectrophoresis with nitroblue tatrazohium coloration (TB), 177 Glycated lysine does the effective diminution of nonenzymatic glycation by D-lysine really highlight its potential use in viva? (L), 2254 Glycated proteins colorimetric detn. of non-enzymatically glycated apolipoprotein B (A), 1074 correln, of HbAic, glycated serum proteins and albumin, and fructosamine with 24-h glucose profile of insulin-dependent pregnant diabetics, 922 l).hysine effectively decreases non-enzymic glycation of proteins in vitro, 384 nonenzymic glycation of immunoghobulins does not impair their immunoreactivity (SN), 1039 Glyceric acldemia biochem. contribution to diagnosis and study of a new case of D-ghyceric acidemia/aciduria (CR), 2148 2382 CLINICALCHEMISTRY,Vol. 35, No. 12, 1989
Glycohemoghobin See Glycated hemoglobin Glycoprotems apphn. of a silver-binding assay to detn. of protein in CSF (SN), 860 changes in concanavalin A-reactive proteins in mflammatory disorders, 2207 decreased immunoreacty. and binding acty. of corticosteroid.binding globulin in serum in septic shock, 1675 detecting serum acidic range glycoproteins using isoehectric focusing on cellulose acetate mambranes high condos, (A), 1083 of Zna2-glycoprotein and lack of a2HS-ghycopratein in ejaculates, 1649 high-yield purifn. of the complex-farming glycoprotein in urine, 577 two-site immunoenzymometry of 52.kDa cathepsin Din cytosols of breast-cancer tissues, 81 Ihycosaminoghycans diagnostic test for mucopolysaccharidosis I. direct method for quantg. excessive urinary glycosaininoglycan excretion, 374 diagnostic test for mucopolysaccharidosis. II. rapid quantn. of ghycosaminoghycan in urine samples one paper matrix, 2074 dimethylmethylene blue-based spectrophotom. of glycosaminoghycana in untreated urine: rapid screening for mucopolysaccharidoses, 1472 lyoxa1 glyoxal: an artefact from metronidazohe and glyoxylic acid in urinary org. acid anal. (TB), 673 Ryoxylic acid glyoxal: an artefact from metronidazohe and glyoxylic acid in urinary org. acid anal. (TB), 673 onadotroplns RIA of -microseminoprotein, a prostatic. secreted protein in sera of men and women, 1497 3ranuhocyte. detn. of Mg2+ in granulocytes, 1404 rowth hormone changes of growth-related hormones and growth factors following pneumanectomy’ I. growth hormone (A), 1150 aloperidoh evain. of EIA for detn, of hahoperidoh, a neuroheptic drug, in serum (A), 1175 how-dose monitoring of haloperidol (A), 1179 alothane quantn. of halothane by headspace gsa chromatog. (A), 1173 hlaptocorrin cobalamin-binding capacity of haptocorrin and transcobalsmin: age-correlated ref. intervals and values from patients, 1447 lieart disease See also Myocardial infarction antiarrhythniic drugs and the cardiac Na channel: current models(S), 748 apolipoprotein E isoform anal, in characterizin[atherogenic risk (A), 1235 epolipoprotein E isoforms in patients with hypertrophic cerdiomyopethy (A), 1070 concns. of Se, Zn, Cu, Fe, Mg, K in blood and heart tissue in coronary heart disease (SN), 851 creatine kinase isoforms in ischemic heart disease (R), 7 diagnostic utility of serum total creatine kinase and creatine kinase-2 in myocardial infarction re-evaluated, 1435 duah-pptn. method evald. for mess, of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in plasma, 265 emetine identified in urine by HPLC, with fluorescence and ultraviolet/diode array detection, in a patient with cerdiomyopathy (CR), 499 fibronectin is unsuitable as a tumor marker in pleural effusions (SN), 166 heterogeneity of serum creatine kinase isoenzyme MM in myocardial infarction: chin. significance and post-synthetic conversion of “abnormal” sub-bands, 206 high alanine aminotransferase activities in plasma, hearts in patients with acute nyocardial infarction, 279 HUP-lipid program: apolipoprotain A-I and B and the apo B/apo A-I ratio (A), 1065 hypomagnesemia and how alk. phosphatase acty. in patients’ (SN), 664 serum after cardiac surgery immunochem. test for CK-MB isoforms (L), 2157 increase of hypoxanthine during cardiac surgery, as measured by an indirect automated enzymatic assay (L), 898 LDL heterogeneity relationships between particle size and coronary disease (A), 1234 lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies, 1380 mess, of autoimmune response against collagen types I, Ill, and IV by enzyme-linked immunosorbent assay, and appln. in infective endocarditia, 246 mess, of urinary heukotrienes by reversedphase liq. chromatog. and RIA, 388 optimized microturbidimetric assay for fibrinogen, 211 patterns of lactate dehydrogenase isoenzymes 1 and 2 in serum on exercise (SN), 301 role of Mg in etiology of cardiovascular disease (A), 1055 S-100a0 protein in blood and urine during open-heart simultaneous surgery, 1942 detn. of pentoxifylline and three metabolites in bioL fluids by hiq. chromatog. (SN), 298 specific binding of cardiac glycoside drugs and endogenous digitalis’like substances to particulate membrane fractions from placenta, 2093 statis. interpretn. of concns, of Mg, Zn, Ca, K, cholesterols, and creatine kinase isoenzymes in men at different stages of ischemic heart disease (SN), 833 streptokinase binds to lactate dehydrogenase subunit-M, which shares an epitope with plasminogen, 69 strong aasocn, of a single nucleotide substitution in the 3’-untranslated region of the apolipoprotein-CIhI gene with common hypertriglyceridemia in Arabs, 256 update on digoxin (5), 1326 Heart disorders heart disorders and concentrations of directly measured atriah natriuretic peptide in plasma, 435 Heart transplant ohigoclonal banding in serum from hearttransplant recipients, 431 serum prolactin as a rejection marker in heart transplantn. (TB), 492 simultaneous deth. of serum neopterin and C- reactive protein as markers of infection in heart-transplant recipients (TB), 1258 Hemsgglutination passive hemagglutinetion assay for HIV antibody screening (Retrocell HIV#{149}) (A), 1210 Hematocrit effect of hematocrit and added heparmn on Ca2 in capillary blood from neonates (SN), 486 Hematofluorometers empirically detd. Pb-poisoning screening cutoff for the Prototluor-Z hematofluorometer (SN), 2104 interlab, comparison of control materials for use with hematofluorometers, 2059 Hematology artificial intelligence program for interpretation of raw data from automated hemotol, instruments (A), 1089 correction factors for extracorporeal pump hemodihution: evaln, using an in-vitro model (A), 1158 performance evaln. of Corning 288 and Nova Stat Profile 1 blood gas systems (A), 1093 Heme effect of ingestion of hemoproteins on fecal excretion of hemes and porphyria, 2290 empirically detd, Pb-poisoning screening cutoff for the Protofluor-Z hematofluorometer (SN), 2104 interaction between pyridine nucleotide coenaymes and heme proteins: possible source of error in assay of activities of coenzyme-linked enzymes (SN), 2129 Zn protoporphyrin/heme ratio: primary test for Fe deficiency in a pediatric population (A), 1114 Hemochromatosis erythrocyte ferritin assay to fmd patients with homozygous hemochromatosia (A), 1083 Hemodlahysis See also Dialysis patients critical appraisal of methods for Al-monitoring program (A), 1114 improved detn. of Vain bioL fluids by electratherm, at. absorption spectrom. (SN), 127 interference with mess, of intact parathyrin in serum from renal dialysis patients (TB), 1543 measuring creatine kinaae MB isoenzyme in a maintenance hemodialysia popn.: chemiluminometric immunoassay and electrophoresis compared (SN), 1965 serum paratbyroid hormone in hemodialysis patients (A), 1140 Hemoglobin See also Glycated hemoglobin apphn. of a silver-binding assay to detn. of protein in CSF (SN), 860 assay of glucose-6-phosphate dehydrogenase ecty. in blood on the Hitachi 737, with simultaneous detn. of Rb (A), 1119 automated detn. of chohinesterase ecty. in plasma and erythrocytes by flow’injection anal., and eppln. to identify sensitive to succinylchaline, subjects 77 disturbance of the detn. of Hb concn, in patients with high heukocyte counts (L), 515 effect of hemoglobinemia on bilirubin assays on Kodak Ektachem 700 and Bilirubinometer (A), 1157 evain. of dry-chem, analyzer, the Chinistat, for blood Hb and serum or plasma constituents (A), 1108 Hb peroxidase acty. for coupled enzymatic reactions (A), 1122 interaction between pyridine nucheotide coenzymes and heme proteins: possible source of error in assay of activities of coenzyme-hinked enzymes (SN), 2129 liq.-chromatog. detn, of acetylated Hb, 33 monoclonal antibody to ‘y chain of fetal Hb used to develop an enzyme immunoassay, 2066 patient-side immunoassay system withs single-use cartridge for measuring analytes in blood (5), 1869 reliability of detn, of whole-blood 0 affinity with blood-gas analyzers and multiwavelength oximeters, 773 unreliable visual estn, of incidence and amount of turbidity, hemohysis, and icterus in serum from hospitalized patients (SN), 837 unusual band on Rb electrophoresis produced by a monoclonal immunoghobulin in serum (TB), 1794 unusual band that binds Rb after ultracentrifn. of hemolyzed plasma hipoprotein sepn. (TB), 495 for Hemogloblnopathles prenatal diagnosis of hemoglobinopathies by using pohymeraae chain reaction and allelespecific ohgonucleotide probes (S), 1854 Hemoglobinuria (Wake Forest University Case Conference): myoglobinurie, hemoghobinuria, acute renal failure (CC), 1713 Hemoglobin variants chromatofocusing and isoelectric focusing in immobilized pH gradients compared for characterization of Rb variants, 425 nephelometric method for quantitating HbF (A), 1199 stability of hemoglobins A, F, 5, and C in dried neonatal whole-blood samples when analyzed by cation-exchange RPLC (A), 1152 Hemoproteins effect of ingestion of hemoproteins on fecal excretion of hemes and porphyria, 2290 Hemorrhagic disease anal, of supplemented vit. Ki (20) in serum microeamples by solid-phase extrn. and narrow-bare HPLC with multichannel uv detection (5), 1288 Hemorrhagic shock increases in aspartata aminatransferaae, creatine kinase in hemorrhagic shock and encephalopathy syndrome (L), 2253 Heparin effect of hematocrit end added heparin on Ca2 in capillary blood from neonates (SN), 486 increased concns. of heparmncofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin 111,52 Hepatic disease See also Liver disease Hepatitis calciferin and cathepsin D-hike acid protease in serum in acute, chronic liver injuries in rats, humans, 2202 generalized likelihood ratio concept and logistic regression anal, for multiple diagnostic categories, 990 CLINICAL CHEMISTRY, Vol. 35, No. 12, 1989 2383
Page 1 and 2: llifi1ll Si Journal of the American
Page 3 and 4: were, Larry 0., 1235, 1282 wie, Lem
Page 5 and 6: gan, Paolo; Montagnoli, Giorgio; Wi
Page 7 and 8: thor, Mike; Martel, P.; O’Donnell
Page 9 and 10: sken, Brigitta C. P. See Leeuwenkam
Page 11 and 12: alouel, Jean-Marc See Wu, Lily L. a
Page 13 and 14: lontagnoli, Giorglo See Degan, Paol
Page 15 and 16: -; Faggian, D.; Floreani, A.; Masie
Page 17 and 18: ,ta, F. See Tamagno, B. ‘vaIl, J.
Page 19 and 20: 1’urcant, A. See Allain, P.; Lain
Page 21 and 22: Volume 35, 1989 SUBJECT INDEX A, ab
Page 23 and 24: Amino acids amino acid anal, for nu
Page 25 and 26: thyroglobulin, thyroid peroxidase,
Page 27 and 28: measurement of estrogen and progest
Page 29 and 30: automated detn, of cholinestarase a
Page 31 and 32: screening for microalbuminuria with
Page 33 and 34: liq.-chromatog. monitoring a! cytos
Page 35 and 36: detn. of Mg2 in granulocytes, 1404
Page 37 and 38: lactate dehydrogenase-1 assay using
Page 39: evaln. of Abbott AD,. analyzer in t
Page 43 and 44: cholestyramine or placebo: differen
Page 45 and 46: 1gM antibodies to Toxoplasma gondii
Page 47 and 48: serum P-amyhase detn. using monocho
Page 49 and 50: Systems EASY ST analyzer (A), 1074
Page 51 and 52: methodoL and chin. multicentar eval
Page 53 and 54: Nucheosides extn. of intracellular
Page 55 and 56: Physostigmine detn, of physostigmin
Page 57 and 58: evaln. of a new linearity material
Page 59 and 60: feline and canine ref. ranges for t
Page 61 and 62: I-RIA for androstenedione in serum
Page 63 and 64: moderate I deficiency, possible exp
Page 65 and 66: line mess, of uv absorbance and ehe
Page 67 and 68: and values from patients, 1447 high

Back Matter (PDF) - Clinical Chemistry

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?